Live Breaking News & Updates on Prnewswire Ardelyx Inc

Stay updated with breaking news from Prnewswire ardelyx inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative. ....

United States , Peter Stein , Fosun Pharma , Drug Administration , Ardelyx Inc , Prnewswire Ardelyx Inc , Office Of New Drugs , Complete Response Letter , New Drug Application , New Drugs , Drug Evaluation , Kyowa Kirin , Knight Therapeutics ,

Ardelyx Announces FDA Advisory Committee Votes that the Benefits of XPHOZAH® (tenapanor) Outweigh its Risks for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative. ....

United States , Mike Raab , Sharon Moe , Fosun Pharma , Indiana University School Of Medicine , Renal Drugs Advisory Committee , Drug Administration , Ardelyx Inc , Advisory Committee , Office Of New Drugs , Prnewswire Ardelyx Inc , New Drugs , Indiana University School , Drug Evaluation , Complete Response Letter , Kyowa Kirin , Knight Therapeutics , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries , Conference Call Announcements ,

National Kidney Foundation and Ardelyx, Inc. Survey Finds Dialysis Patients Struggle to Maintain Serum Phosphorus Levels

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX) in partnership with the National Kidney Foundation (NKF), today announced results from a survey of patients with. ....

Joseph Vassalotti , Lauraa Williams , Prnewswire Ardelyx Inc , National Kidney Foundation , Ardelyx Inc , Ardelyx Patient Advisory Council , Patient Advisory Council , National Kidney ,

Ardelyx Reports Third Quarter 2022 Financial Results and Recent Business Highlights

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative. ....

United States , Mike Raab , Susan Lucak , Fosun Pharma , Exchange Commission On , Ardelyx Inc , Advisory Committee , Exchange Commission , Company Annual Report On Form , American College Of Gastroenterology , Prnewswire Ardelyx Inc , Japanese Ministry Of Health , American Society Of Nephrology , Kyowa Kirin Co Ltd , Business Highlights , American College , Scientific Meeting , Product Theater , Irritable Bowel Syndrome , Continuing Medical Education , Personalizing Care , New Drug Application , Japanese Ministry , American Society , Kyowa Kirin , Serious Dehydration ,

Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative. ....

United States , Orange County Convention Center , Fosun Pharma , Prnewswire Ardelyx Inc , American Society Of Nephrology , Kyowa Kirin Co Ltd , Ardelyx Inc , American Society , Kidney Week , Kyowa Kirin , Poster Presentations , Predictive Value , Early Response , Patients Receiving Maintenance , Exhibit Hall , Serum Phosphorus , With Tenapanor , Chronic Kidney Disease , Dialysis With Severe , Reduces Interdialytic Weight Gain , Post Hoc Analysis , Kirin Poster Presentations , Japanese Hemodialysis Patients , Randomized Phase , Tenapanor Added , Phosphate Binders ,